Company: NCEL
Filing Date: 2025-10-24
Form Type: POS AM
Source: 0001213900-25-102149
Chunk: 77

Company: NewcelX Ltd.
Filing Date: 2025-10-24
Form: POS AM
Chunk 77
---
 post-effective amendment to registration statement on Form F-1 to be signed on its behalf
by the undersigned, thereunto duly authorized, in Zurich, Switzerland, on October 24, 2025.

| NLS PHARMACEUTICS LTD. |                         |
| By:                    | /s/ Alexander Zwyer     |
|                        | Alexander Zwyer         |
|                        | Chief Executive Officer |

Pursuant to the requirements
of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates
indicated.

| Signature                 
 *                         |     | Title                       
 Chief Executive Officer     
 and Director                |     | Date     
 October  
 24, 2025 |
|:--------------------------|:----|:----------------------------|:----|:---------|
| Alexander Zwyer           |     | -Principal Executive        
 Officer                     |     |          |
| *                         |     | Chief Financial Officer     
 and Chief Operating Officer |     | October  
 24, 2025 |
| Nicole Fernandez–McGovern |     | -Principal Financial        
 and Accounting Officer      |     |          |
| *                         |     | Chairman of the Board       
 of Directors                |     | October  
 24, 2025 |
| Ronald Hafner             |     |                             |     |          |
| *                         |     | Director                    |     | October  
 24, 2025 |
| Florence Allouche         
 Aknin                     |     |                             |     |          |
| *                         |     | Director                    |     | October  
 24, 2025 |
| Gian-Marco Rinaldi        
 de la Cruz                |     |                             |     |          |
| *                         |     | Director                    |     | October  
 24, 2025 |
| Olivier Samuel            |     |                             |     |          |

| * By: | /s/              
 Alexander Zwyer  |
|       | Alexander Zwyer  |
|       | Attorney-in-fact |

<div align='center'>II-7

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</div>

Pursuant to the Securities
Act of 1933, as amended, the undersigned, Puglisi & Associates, the duly authorized representative in the United States of NLS Pharmaceutics
Ltd., has signed this registration statement on October 24, 2025.

| PUGLISI & ASS